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Background:  Patency rates are still suboptimal in patients with peripheral artery disease (PAD) undergoing percutaneous intervention. 
Atherosclerotic plaque characteristics may be predictive of future events in patients with PAD.
methods:  Excised plaques from 113 de novo lesions of 92 symptomatic patients were evaluated following directional atherectomy 
(SilverHawk® or TurboHawk™ Peripheral Plaque Excision Systems (Covidien/ev3, Plymouth, MN) of the superficial femoral artery during 
conduction of the DEFINITIVE LE trial. Immunohistochemistry was performed to stain for macrophages (CD68, CD163), T-lymphocytes 
(CD3), HLA-DR, red blood cells (glycophorin A), endothelial cells (ulex), smooth muscle cells (HHF), Toll-like receptor 4, RAGE and 
ENRAGE. In addition, in 20 randomly selected cases RNA and protein profiling were performed for total of 90 genes and 15 proteins.
results:  Histology showed acute or organizing thrombus in 27 patients (29%). Patients with thrombus had significantly higher CD163, 
HLA-DR, and glycophorin A expression (p=0.01, p=0.02 and p=0.01) than those without thrombus. Thrombosis cases also showed 
increased expression of numerous inflammatory genes such as TNF, IL-8 and chemokines (CCL17, 26, CXCL1, 3, and 6) as well as 
increased protein levels including IL-6 and IL-8. Primary patency at 6 month in patients with presence of thrombus was significantly lower 
than in patients without thrombus (59% [10/17] vs. 87% [40/46], p=0.014), while this effect was not sustained at 12 months (61% [14/23] vs. 
67% [42/63], p=0.62).
conclusion:  The current analysis revealed that peripheral atherothrombotic plaque is associated with increased expression of 
inflammatory markers and worse patency outcome at 6 months. However, this early distinguishing feature was not found to be of predictive 
value with respect to clinical outcome at 12 months.
